Table: Cosmos Pharmaceutical -2023/24 group results

Cosmos Pharmaceutical

12/07/2024 07:00

Jul 12 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2024    May 31, 2023   May 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          964.99          827.70        1.04 trln      515.20   
               (+16.6 pct)     (+9.6 pct)     (+7.5 pct)    (+8.1 pct) 
  Operating       31.50           30.13          31.60         16.00   
               (+4.6 pct)      (+1.1 pct)     (+0.3 pct)    (+1.0 pct) 
  Recurring       34.30           33.09          34.40         17.47   
               (+3.7 pct)      (+0.7 pct)     (+0.3 pct)    (+0.7 pct) 
  Net
  Net             24.45           23.80          24.50         11.79   
               (+2.8 pct)      (+2.8 pct)     (+0.2 pct)    (+1.7 pct) 
  EPS          617.22 yen      600.96 yen     309.12 yen    148.76 yen 
  Ann Div      120.00 yen      100.00 yen      65.00 yen               
  -Q2 Div       60.00 yen       42.50 yen      32.50 yen               
  -Q4 Div       60.00 yen       57.50 yen      32.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T